These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20639555)

  • 1. Buprenorphine may boost HIV treatment.
    Kuehn BM
    JAMA; 2010 Jul; 304(3):261-3. PubMed ID: 20639555
    [No Abstract]   [Full Text] [Related]  

  • 2. Buprenorphine in primary HIV care clinics: a big pill to swallow.
    Lucas GM
    Hopkins HIV Rep; 2004 Jul; 16(4):5-7. PubMed ID: 15386835
    [No Abstract]   [Full Text] [Related]  

  • 3. Integration of buprenorphine for substance-abuse treatment by HIV care providers.
    Friedland G; Vlahov D
    J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1():S1-2. PubMed ID: 21317588
    [No Abstract]   [Full Text] [Related]  

  • 4. An integrated program of buprenorphine in the primary care setting for HIV(+) persons in Rhode Island.
    Mitty J; Macleod C; Loewenthal H; Thompson L; Bazerman L
    Med Health R I; 2007 May; 90(5):145-7. PubMed ID: 17557657
    [No Abstract]   [Full Text] [Related]  

  • 5. Models for integrating buprenorphine therapy into the primary HIV care setting.
    Basu S; Smith-Rohrberg D; Bruce RD; Altice FL
    Clin Infect Dis; 2006 Mar; 42(5):716-21. PubMed ID: 16447120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention.
    Altice FL; Sullivan LE; Smith-Rohrberg D; Basu S; Stancliff S; Eldred L
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S178-83. PubMed ID: 17109304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care.
    Cheever LW; Kresina TF; Cajina A; Lubran R
    J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1():S3-6. PubMed ID: 21317591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk reduction with buprenorphine-naloxone and methadone: patient's choice.
    Newman RG
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):e142. PubMed ID: 25197828
    [No Abstract]   [Full Text] [Related]  

  • 9. The medical management of opioid dependence in HIV primary care settings.
    Lum PJ; Tulsky JP
    Curr HIV/AIDS Rep; 2006 Nov; 3(4):195-204. PubMed ID: 17089480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice".
    Woody G; Bruce D; Korthuis PT; Chhatre S; Hillhouse M; Jacobs P; Sorensen J; Saxon AJ; Poole S; Metzger D; Ling W
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):e142-3. PubMed ID: 25243431
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
    Lott DC; Strain EC; Brooner RK; Bigelow GE; Johnson RE
    J Subst Abuse Treat; 2006 Sep; 31(2):187-94. PubMed ID: 16919747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine: a new treatment for opioid addiction.
    Harv Ment Health Lett; 2001 Feb; 17(8):6-7. PubMed ID: 11175458
    [No Abstract]   [Full Text] [Related]  

  • 14. Medication helps make therapy work for teens addicted to prescription opioids.
    Kuehn BM
    JAMA; 2010 Jun; 303(23):2343-5. PubMed ID: 20551400
    [No Abstract]   [Full Text] [Related]  

  • 15. Buprenorphine: a potential new treatment option for opioid dependence.
    Srivastava A; Kahan M
    CMAJ; 2006 Jun; 174(13):1835. PubMed ID: 16785455
    [No Abstract]   [Full Text] [Related]  

  • 16. Maintenance buprenorphine for opioid users.
    Law FD; Nutt DJ
    Lancet; 2003 Feb; 361(9358):634-5. PubMed ID: 12606172
    [No Abstract]   [Full Text] [Related]  

  • 17. Buprenorphine: effective treatment of opioid addiction starts in the office.
    Fiellin DA
    Am Fam Physician; 2006 May; 73(9):1513-4. PubMed ID: 16719242
    [No Abstract]   [Full Text] [Related]  

  • 18. Perioperative implications of buprenorphine maintenance treatment for opioid addiction.
    Gevirtz C; Frost EA; Bryson EO
    Int Anesthesiol Clin; 2011; 49(1):147-55. PubMed ID: 21239911
    [No Abstract]   [Full Text] [Related]  

  • 19. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
    Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113
    [No Abstract]   [Full Text] [Related]  

  • 20. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Cottrill CB; Matson SC
    Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.